Published in Prion on September 28, 2012
Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochim Biophys Acta (2013) 1.20
Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol (2014) 0.85
Peptidyl arginine deiminase-4-deficient mice are protected against kidney and liver injury after renal ischemia and reperfusion. Am J Physiol Renal Physiol (2016) 0.75
Implications of DNA Methylation in Parkinson's Disease. Front Mol Neurosci (2017) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Rheumatoid arthritis. Lancet (2010) 9.37
Astrocytes: biology and pathology. Acta Neuropathol (2009) 8.43
Human PAD4 regulates histone arginine methylation levels via demethylimination. Science (2004) 5.46
Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol (2009) 5.27
Histone deimination antagonizes arginine methylation. Cell (2004) 5.19
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays (2003) 5.04
PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med (2010) 4.74
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest (2012) 4.31
Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol (2008) 3.14
Molecular mechanisms of prion pathogenesis. Annu Rev Pathol (2008) 3.05
Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol (2004) 2.74
Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood (2009) 2.50
Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum (2007) 2.40
Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol (2008) 2.27
Astrocyte calcium waves: what they are and what they do. Glia (2006) 2.17
Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem (2008) 1.93
Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol (2008) 1.93
Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer (2009) 1.78
Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol (2012) 1.75
The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res (2006) 1.71
Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. Biochemistry (2010) 1.66
Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res (2005) 1.57
Astrocyte calcium elevations: properties, propagation, and effects on brain signaling. Glia (2006) 1.55
Myelin in multiple sclerosis is developmentally immature. J Clin Invest (1994) 1.52
Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis (2011) 1.45
The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem (1995) 1.42
Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry (2000) 1.40
ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev Biol (2003) 1.37
Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem (1989) 1.36
Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol Cell Endocrinol (2007) 1.34
Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest Ophthalmol Vis Sci (2006) 1.32
Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem (2002) 1.31
Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene (2010) 1.27
Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol (1996) 1.26
Role for PADI6 and the cytoplasmic lattices in ribosomal storage in oocytes and translational control in the early mouse embryo. Development (2008) 1.22
Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat Commun (2012) 1.20
Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J Invest Dermatol (2005) 1.15
Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech (2008) 1.14
Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism. J Neurochem (2009) 1.12
Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability. Dev Biol (2011) 1.12
The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations. Cell Mol Life Sci (2005) 1.08
The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatol Int (2009) 0.98
Regulation of mouse oocyte microtubule and organelle dynamics by PADI6 and the cytoplasmic lattices. Dev Biol (2010) 0.98
Peptidylarginine deiminase isoforms are differentially expressed in the anagen hair follicles and other human skin appendages. J Invest Dermatol (2005) 0.97
Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol (2008) 0.97
Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases. Int J Cosmet Sci (2007) 0.95
Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J Comp Neurol (2004) 0.94
Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol (2009) 0.90
Regulation of the expression of peptidylarginine deiminase type II gene (PADI2) in human keratinocytes involves Sp1 and Sp3 transcription factors. J Invest Dermatol (2005) 0.83
Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins. J Neuropathol Exp Neurol (2011) 0.82
Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra. Neurosci Lett (2011) 0.82
Expression and citrullination of keratin in synovial tissue of rheumatoid arthritis. Rheumatol Int (2009) 0.80
Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain. J Neurosci Res (2010) 0.79
Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases. Biochem J (2012) 0.79
Effect of enzymatic deimination on the conformation of recombinant prion protein. Biochim Biophys Acta (2009) 0.78
Marburg's variant of multiple sclerosis correlates with a less compact structure of myelin basic protein. Mol Cell Biol Res Commun (1999) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med (2006) 2.87
Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes. J Neurosurg (2014) 2.04
High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis (2007) 1.88
Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res (2005) 1.57
Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice. Hepatology (2010) 1.56
Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology (2009) 1.55
Antioxidant, EUK-8, prevents murine dilated cardiomyopathy. Circ J (2009) 1.52
Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J (2002) 1.52
Acute serious rebleeding after angiographically successful coil embolization of ruptured cerebral aneurysms. Acta Neurochir (Wien) (2010) 1.42
Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci U S A (2006) 1.37
Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. Am J Pathol (2002) 1.30
Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One (2013) 1.30
Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun (2008) 1.29
Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur J Neurosci (2006) 1.22
Passage of chronic wasting disease prion into transgenic mice expressing Rocky Mountain elk (Cervus elaphus nelsoni) PrPC. J Gen Virol (2006) 1.20
Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol (2005) 1.17
Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein. Hybridoma (Larchmt) (2006) 1.13
Induction of myasthenia by immunization against muscle-specific kinase. J Clin Invest (2006) 1.13
cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. Biochem J (2003) 1.12
SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun (2004) 1.12
CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils. J Leukoc Biol (2007) 1.06
Switching strategy for mechanical thrombectomy of acute large vessel occlusion in the anterior circulation. Stroke (2013) 1.04
The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res Mol Brain Res (2004) 1.03
Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). J Biol Chem (2002) 1.03
Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. Arch Biochem Biophys (2002) 1.02
The prevalence of human endogenous retroviruses in cerebrospinal fluids from patients with sporadic Creutzfeldt-Jakob disease. J Clin Virol (2009) 1.02
SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev (2006) 1.01
Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver. FEBS Lett (2004) 0.99
Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice. J Virol (2008) 0.99
Association of sporadic Creutzfeldt-Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population. Neurogenetics (2005) 0.98
Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol (2005) 0.98
Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells. Immunol Lett (2009) 0.97
Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process. Exp Gerontol (2004) 0.97
Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol (2008) 0.97
Ascorbic acid depletion enhances expression of the sodium-dependent vitamin C transporters, SVCT1 and SVCT2, and uptake of ascorbic acid in livers of SMP30/GNL knockout mice. Arch Biochem Biophys (2010) 0.96
Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2). J Hum Genet (2004) 0.95
Activation of mitogen-activated protein kinases in hamster brains infected with 263K scrapie agent. J Neurochem (2005) 0.95
Complete lack of vitamin C intake generates pulmonary emphysema in senescence marker protein-30 knockout mice. Am J Physiol Lung Cell Mol Physiol (2010) 0.95
The pathogenic mechanisms of prion diseases. Mech Ageing Dev (2002) 0.94
Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J (2005) 0.94
The involvement of cellular prion protein in the autophagy pathway in neuronal cells. Mol Cell Neurosci (2008) 0.93
Polymorphisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet (2004) 0.93
Rescue forced-suction thrombectomy using the reperfusion catheter of the Penumbra System for thromboembolism during coil embolization of ruptured cerebral aneurysms. Neurosurgery (2012) 0.92
Scrapie infection activates the replication of ecotropic, xenotropic, and polytropic murine leukemia virus (MuLV) in brains and spinal cords of senescence-accelerated mice: implication of MuLV in progression of scrapie pathogenesis. Biochem Biophys Res Commun (2006) 0.92
JAK-STAT signaling pathway mediates astrogliosis in brains of scrapie-infected mice. J Neurochem (2007) 0.92
Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis. Am J Pathol (2011) 0.92
Correlations between neuronal loss, decrease of memory, and decrease expression of brain-derived neurotrophic factor in the gerbil hippocampus during normal aging. Exp Neurol (2006) 0.91
Determination of dehydroascorbic acid in mouse tissues and plasma by using tris(2-carboxyethyl)phosphine hydrochloride as reductant in metaphosphoric acid/ethylenediaminetetraacetic acid solution. Biol Pharm Bull (2010) 0.91
Role of DNA methylation in transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus. J Rheumatol (2002) 0.91
Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice. Biochem Biophys Res Commun (2008) 0.91
Time course of vitamin C distribution and absorption after oral administration in SMP30/GNL knockout mice. Nutrition (2010) 0.91
Effect of vitamin C depletion on age-related hearing loss in SMP30/GNL knockout mice. Biochem Biophys Res Commun (2009) 0.91
Pathophysiological significance of senescence marker protein-30. Geriatr Gerontol Int (2010) 0.91
Mitochondrial reactive oxygen species generation by the SDHC V69E mutation causes low birth weight and neonatal growth retardation. Mitochondrion (2010) 0.91
Targeting prion amyloid deposits in vivo. J Neuropathol Exp Neurol (2004) 0.91
Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference. Prion (2011) 0.91
Age-related difference of site-specific histone modifications in rat liver. Biogerontology (2008) 0.90
Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease. Neurobiol Aging (2006) 0.90
A selective NFkappaB inhibitor, DHMEQ, reduced atherosclerosis in ApoE-deficient mice. J Atheroscler Thromb (2006) 0.90
Early ventriculoperitoneal shunt placement after severe aneurysmal subarachnoid hemorrhage: role of intraventricular hemorrhage and shunt function. Neurosurgery (2010) 0.90
Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol (2009) 0.90
Oxidative stress impairs autophagic flux in prion protein-deficient hippocampal cells. Autophagy (2012) 0.90
Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases. J Neuropathol Exp Neurol (2009) 0.90